Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG

cenersen

solution for injection, intravenous infusion, 0.1 mg/kg/h x 24h x 4 days, and 0.4 mg/kg/h x 3h x 4 days

DRUG

placebo

solution for injection, intravenous infusion, 0.1 mg/kg/h x 24h x 4 days, and 0.4 mg/kg/h x 3h x 4 days

DRUG

idarubicin, cytarabine